Download PDF
J Neurol Surg B Skull Base 2021; 82(S 03): e148-e154
DOI: 10.1055/s-0040-1701219
Original Article

Surgical Treatment of Sinonasal Mucosal Melanoma in Patients Treated with Systemic Immunotherapy

Tiffany N. Chao
1   Department of Otorhinolaryngology, Head and Neck Surgery, University of Pennsylvania Health System, Philadelphia, Pennsylvania, United States
,
Edward C. Kuan 
2   Department of Otolaryngology, Head and Neck Surgery, University of California—Irvine, Irvine, California, United States
,
Charles C. L. Tong
1   Department of Otorhinolaryngology, Head and Neck Surgery, University of Pennsylvania Health System, Philadelphia, Pennsylvania, United States
,
Michael A. Kohanski
1   Department of Otorhinolaryngology, Head and Neck Surgery, University of Pennsylvania Health System, Philadelphia, Pennsylvania, United States
,
M. Sean Grady
3   Department of Neurosurgery, University of Pennsylvania Health System, Philadelphia, Pennsylvania, United States
,
James N. Palmer
1   Department of Otorhinolaryngology, Head and Neck Surgery, University of Pennsylvania Health System, Philadelphia, Pennsylvania, United States
,
Nithin D. Adappa
1   Department of Otorhinolaryngology, Head and Neck Surgery, University of Pennsylvania Health System, Philadelphia, Pennsylvania, United States
,
Bert W. O'Malley Jr.
1   Department of Otorhinolaryngology, Head and Neck Surgery, University of Pennsylvania Health System, Philadelphia, Pennsylvania, United States
› Author Affiliations Funding None.
› Further Information
    Permissions and Reprints

Abstract

Objective Surgical resection is widely accepted as a critical component for definitive treatment of sinonasal mucosal melanoma. Systemic immunotherapy, including multiple newer agents, has been used to treat metastatic or unresectable disease. In this study, we examine its efficacy in locoregional control when used in conjunction with surgical resection for primary mucosal lesions.

Design Present study is a retrospective review of all patients at a tertiary academic medical center with primary sinonasal mucosal melanoma and distant metastatic disease.

Results A total of four patients were identified. In all cases, patients were treated with a combination of surgical resection of the primary tumor and systemic immunotherapy. Three patients were initially treated with surgery at the primary site followed by immunotherapy for distant metastases. Response to immunotherapy at the sites of primary and metastatic disease was seen in two patients. All four patients developed progression or recurrence at the primary site following initiation of immunotherapy for which they underwent surgical resection. One patient remains in follow-up without evidence of disease 20 months after initial treatment; three succumbed to the disease at 135, 37, and 16 months after initial treatment.

Conclusion Surgical resection for local control plays a critically important role in the treatment of sinonasal mucosal melanoma regardless of the presence of metastases and whether immunotherapy will be given. This case series suggests that, though immunotherapy may demonstrate efficacy in managing distant disease, surgery should remain the first-line treatment for the primary site.

Keywords

mucosal melanoma - sinonasal malignancy - endoscopic skull base surgery - immunotherapy

Note

This article was originally presented as a poster presentation at the North American Skull Base Society Annual Meeting in Coronado, California on February 16, 2018.




Publication History

Received: 05 April 2019

Accepted: 29 August 2019

Article published online:
07 February 2020

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 

  • References

  • 1 Moreno MA, Roberts DB, Kupferman ME. et al. Mucosal melanoma of the nose and paranasal sinuses, a contemporary experience from the M. D. Anderson Cancer Center. Cancer 2010; 116 (09) 2215-2223
    PubMedGoogle Scholar
  • 2 Roth TN, Gengler C, Huber GF, Holzmann D. Outcome of sinonasal melanoma: clinical experience and review of the literature. Head Neck 2010; 32 (10) 1385-1392
    CrossrefPubMedGoogle Scholar
  • 3 Lombardi D, Bottazzoli M, Turri-Zanoni M. et al. Sinonasal mucosal melanoma: A 12-year experience of 58 cases. Head Neck 2016; 38 (S1, Suppl 1): E1737-E1745
    CrossrefPubMedGoogle Scholar
  • 4 Gore MR, Zanation AM. Survival in sinonasal melanoma: a meta-analysis. J Neurol Surg B Skull Base 2012; 73 (03) 157-162
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Sayed Z, Migliacci JC, Cracchiolo JR. et al. Association of Surgical approach and margin status with oncologic outcomes following gross total resection for sinonasal melanoma. JAMA Otolaryngol Head Neck Surg 2017; 143 (12) 1220-1227
    CrossrefPubMedGoogle Scholar
  • 6 Kashat L, Le CH, Chiu AG. The role of targeted therapy in the management of sinonasal malignancies. Otolaryngol Clin North Am 2017; 50 (02) 443-455
    CrossrefPubMedGoogle Scholar
  • 7 Amit M, Na'ara S, Hanna EY. Contemporary treatment approaches to sinonasal mucosal melanoma. Curr Oncol Rep 2018; 20 (02) 10
    CrossrefPubMedGoogle Scholar
  • 8 Schaefer T, Satzger I, Gutzmer R. Clinics, prognosis and new therapeutic options in patients with mucosal melanoma: a retrospective analysis of 75 patients. Medicine (Baltimore) 2017; 96 (01) e5753
    CrossrefPubMedGoogle Scholar
  • 9 Crippen MM, Kılıç S, Eloy JA. Updates in the management of sinonasal mucosal melanoma. Curr Opin Otolaryngol Head Neck Surg 2018; 26 (01) 52-57
    CrossrefPubMedGoogle Scholar
  • 10 Essner R, Lee JH, Wanek LA, Itakura H, Morton DL. Contemporary surgical treatment of advanced-stage melanoma. Arch Surg 2004; 139 (09) 961-966
    CrossrefPubMedGoogle Scholar
  • 11 Lee G, Baek C-H, Choi NY, Chung MK. The prognostic role of the surgical approach and adjuvant therapy in operable mucosal melanoma of the head and neck. Clin Exp Otorhinolaryngol 2017; 10 (01) 97-103
    CrossrefPubMedGoogle Scholar
  • 12 Robin TP, Jones BL, Gordon OM. et al. A comprehensive comparative analysis of treatment modalities for sinonasal malignancies. Cancer 2017; 123 (16) 3040-3049
    CrossrefPubMedGoogle Scholar
  • 13 Lee K, Ch'ng S, Shannon KF, Ashford B. Sinonasal mucosal melanoma. In: Encyclopedia of Otolaryngology, Head and Neck Surgery. Berlin, Heidelberg: Springer, Berlin, Heidelberg; 2013: 2432-2438
  • 14 Yde SS, Sjoegren P, Heje M, Stolle LB. Mucosal melanoma: a literature review. Curr Oncol Rep 2018; 20 (03) 28
    CrossrefPubMedGoogle Scholar
  • 15 Gal TJ, Silver N, Huang B. Demographics and treatment trends in sinonasal mucosal melanoma. Laryngoscope 2011; 121 (09) 2026-2033
    CrossrefPubMedGoogle Scholar
  • 16 Amit M, Tam S, Abdelmeguid AS. et al. Patterns of treatment failure in patients with sinonasal mucosal melanoma. Ann Surg Oncol 2018; 25 (06) 1723-1729
    CrossrefPubMedGoogle Scholar
  • 17 Won T-B, Choi KY, Rhee C-S. et al. Treatment outcomes of sinonasal malignant melanoma: a Korean multicenter study. Int Forum Allergy Rhinol 2015; 5 (10) 950-959
    CrossrefPubMedGoogle Scholar
  • 18 Sun C-Z, Li Q-L, Hu Z-D, Jiang Y-E, Song M, Yang A-K. Treatment and prognosis in sinonasal mucosal melanoma: a retrospective analysis of 65 patients from a single cancer center. Head Neck 2014; 36 (05) 675-681
    CrossrefPubMedGoogle Scholar
  • 19 Tas F, Keskin S, Karadeniz A. et al. Noncutaneous melanoma have distinct features from each other and cutaneous melanoma. Oncology 2011; 81 (5,6): 353-358
    CrossrefPubMedGoogle Scholar
  • 20 Miglani A, Patel SH, Kosiorek HE, Hinni ML, Hayden RE, Lal D. Endoscopic resection of sinonasal mucosal melanoma has comparable outcomes to open approaches. Am J Rhinol Allergy 2017; 31 (03) 200-204
    CrossrefPubMedGoogle Scholar
  • 21 Cao W, Guan B, Yu A. et al. Treatment and outcomes of endoscopic surgery and traditional open resection in sinonasal mucosal melanoma. Acta Otolaryngol 2017; 137 (08) 862-867
    CrossrefPubMedGoogle Scholar
  • 22 Caspers CJI, Dronkers EAC, Monserez D, Wieringa MH, Baatenburg de Jong RJ, Hardillo JAU. Adjuvant radiotherapy in sinonasal mucosal melanoma: A retrospective analysis. Clin Otolaryngol 2018; 43 (02) 617-623
    CrossrefPubMedGoogle Scholar
  • 23 Amit M, Tam S, Abdelmeguid AS. et al. Role of adjuvant treatment in sinonasal mucosal melanoma. J Neurol Surg B Skull Base 2017; 78 (06) 512-518
    Article in Thieme ConnectPubMedGoogle Scholar
  • 24 Postow MA, Luke JJ, Bluth MJ. et al. Ipilimumab for patients with advanced mucosal melanoma. Oncologist 2013; 18 (06) 726-732
    CrossrefPubMedGoogle Scholar
  • 25 Del Vecchio M, Di Guardo L, Ascierto PA. et al. Efficacy and safety of ipilimumab 3mg/kg in patients with pretreated, metastatic, mucosal melanoma. Eur J Cancer 2014; 50 (01) 121-127
    CrossrefPubMedGoogle Scholar
  • 26 D'Angelo SP, Larkin J, Sosman JA. et al. Efficacy and safety of nivolumab alone or in combination with ipilimumab in patients with mucosal melanoma: a pooled analysis. J Clin Oncol 2017; 35 (02) 226-235
    CrossrefPubMedGoogle Scholar
  • 27 Lund VJ, Chisholm EJ, Howard DJ, Wei WI. Sinonasal malignant melanoma: an analysis of 115 cases assessing outcomes of surgery, postoperative radiotherapy and endoscopic resection. Rhinology 2012; 50 (02) 203-210
    Google Scholar
  • 28 Ganti A, Raman A, Shay A. et al. Treatment modalities in sinonasal mucosal melanoma: A national cancer database analysis. Laryngoscope 2019
    Google Scholar
  • 29 Penel N, Mallet Y, Mirabel X, Van JT, Lefebvre J-L. Primary mucosal melanoma of head and neck: prognostic value of clear margins. Laryngoscope 2006; 116 (06) 993-995
    CrossrefPubMedGoogle Scholar
  • 30 Manjunath L, Derousseau T, Batra PS. Prognostic value of surgical margins during endoscopic resection of paranasal sinus malignancy. Int Forum Allergy Rhinol 2015; 5 (05) 454-459
    CrossrefPubMedGoogle Scholar
  • 31 Harrow BR, Batra PS. Sinonasal quality of life outcomes after minimally invasive resection of sinonasal and skull-base tumors. Int Forum Allergy Rhinol 2013; 3 (12) 1013-1020
    CrossrefPubMedGoogle Scholar
  • 32 Ransom ER, Doghramji L, Palmer JN, Chiu AG. Global and disease-specific health-related quality of life after complete endoscopic resection of anterior skull base neoplasms. Am J Rhinol Allergy 2012; 26 (01) 76-79
    CrossrefPubMedGoogle Scholar
  • 33 Glicksman JT, Parasher AK, Brooks SG. et al. Sinonasal quality of life after endoscopic resection of malignant sinonasal and skull base tumors. Laryngoscope 2018; 128 (04) 789-793
    CrossrefPubMedGoogle Scholar
  • 34 Derousseau T, Manjunath L, Harrow B, Zhang S, Batra PS. Long-term changes in quality of life after endoscopic resection of sinonasal and skull-base tumors. Int Forum Allergy Rhinol 2015; 5 (12) 1129-1135
    CrossrefPubMedGoogle Scholar
  • 35 Ledderose GJ, Leunig A. Surgical management of recurrent sinonasal mucosal melanoma: endoscopic or transfacial resection. Eur Arch Otorhinolaryngol 2015; 272 (02) 351-356
    CrossrefPubMedGoogle Scholar